Skip to content

AI & AutomationGuide

AI for Pharma and Chemical Documentation in Gujarat: COAs, Specs and SOP Search

AI can help pharma and chemical companies find answers in SOPs and specifications and pull data out of incoming certificates of analysis, as long as it only searches approved documents, shows its source every time, and leaves every GMP decision with qualified people. It is a tool for finding and drafting, not a quality system.

Written by
Patel Software Editorial Team
Published
Reading time
5 min

Where does document time actually go in a pharma or chemical plant?

Gujarat has one of India’s largest concentrations of pharma and chemical manufacturing, from the estates around Vadodara to Ankleshwar and beyond. In most of these plants, a surprising share of skilled time goes into documents: checking incoming COAs against specifications, finding the current revision of an SOP, answering a customer’s question about a test method, or pulling together information for an audit.

None of this is the core work. It is the paperwork around it, and it depends heavily on people who know where everything lives.

What can AI do with certificates of analysis?

An AI document reader can take an incoming COA, whether a PDF or a scan, and extract the fields you care about: supplier, material, batch number, manufacturing and expiry dates, each test parameter and its result. It can then compare each result with your specification for that material and flag anything outside limits or missing.

What it should not do is accept or reject the material. The extracted data and flags go to a qualified person, who reviews them against the original document and makes the decision. The software saves the retyping and the first comparison; the person keeps the judgement.

How does SOP and specification search work?

The usual approach links an existing AI model to your approved document library, so answers are built only from those documents and each answer cites the exact document, revision and section it came from. Staff ask in plain language, such as “What is the drying time in the line 2 cleaning SOP?”, and get a short answer with a link to the source.

The details matter: the system must index only current, approved revisions, respect who is allowed to see which documents, and say plainly when it cannot find an answer instead of making one up. Our AI development work in Vadodara starts from those rules before any model is chosen.

What must stay with people?

Batch release. Deviation investigations and their conclusions. Change control decisions. CAPA. Anything submitted to a regulator or a customer as a statement of quality. AI can help find related documents or draft a first summary for a reviewer, but the decision and the signature stay with qualified staff.

How do GMP and data-integrity rules apply?

Indian manufacturers work under the revised Schedule M good manufacturing practice requirements notified in December 2023, and exporters also face their customers’ regulators, such as the US FDA’s 21 CFR Part 11 rules on electronic records and signatures. The WHO guideline on data integrity sets out the ALCOA+ principles: records should be attributable, legible, contemporaneous, original and accurate, among other things.

For an AI tool, that means a few concrete design rules. Keep the original document and link every extracted value back to it. Log who reviewed and approved what, and when. Never let the AI overwrite a source record. And treat the tool as a computerised system that may need validating in proportion to its risk, which your quality team should assess before it is used for GMP work.

What about security and where documents go?

Agree up front where documents are stored, which outside AI services process them, whether those services keep or train on your data, and who can access what. Many companies start with documents that are already shared widely inside the business, and keep formulations and customer-confidential files out of scope until those questions are settled. The NIST AI Risk Management Framework is a useful checklist for this conversation.

How do you measure accuracy before relying on it?

Build a test set from real past documents where the correct answer is already known: a few hundred COAs with their verified values, or a list of questions about your SOPs with the right answers and sources. Run the tool on the whole set and compare its output with the known answers, field by field and question by question.

Count three things separately: answers that are right, answers that are wrong, and cases where the tool says it doesn’t know. A tool that says “not found” when unsure is far safer than one that guesses, so treat confident wrong answers as the most serious failure. Look at the wrong answers one by one. Many come from poor scans, unusual layouts or out-of-date documents in the library, and can be fixed at the source.

Repeat the test whenever the model, the prompts or the document set changes. In a regulated plant, keep the test results with the system’s records, so anyone reviewing the tool later can see how it was checked and what it was approved to do.

A practical rule many quality teams adopt: the tool can propose, a person must dispose. Every extracted value and every answer carries a link back to its source, and nothing reaches a GMP record without a named reviewer. That keeps the time saving while keeping accountability exactly where your regulators expect it.

What does a careful pilot look like?

Pick one document type and one team. Collect a test set of real past documents with known correct answers. Run the tool on them, compare its output with what a person would have done, and track every miss. Only when the results hold up does the tool go into daily use, still with a person reviewing.

If your quality or regulatory team spends hours a week on this kind of paperwork, tell us which documents take the most time and we will say honestly whether AI is a good fit.

Frequently asked questions

Does an AI document tool need validation?

If it is used for GMP-relevant work, it should be assessed like any computerised system, with validation effort proportionate to its risk. Your quality team decides the approach. Keeping a person reviewing every output reduces the risk considerably.

Can it read scanned COAs and old paper records?

Often, yes, if the scans are clear. Accuracy drops with poor scans, handwriting and unusual layouts, which is why extracted values should always be checked against the original.

Will our documents be used to train someone else’s AI model?

That depends on the AI service and the agreement. Many business offerings commit not to train on customer data. We confirm this for any service before proposing it, and some documents can be kept out of scope entirely.

Can the search tell different SOP revisions apart?

It should. A well-built system indexes only the current approved revision by default, shows the revision number with every answer, and can search older revisions separately when someone needs history.

Which documents should we start with?

Ones that are high-volume, fairly standard in layout and low-risk to get wrong at the draft stage. Supplier COAs for regularly bought materials, or searching widely used SOPs, are common starting points.

Sources and further reading

  1. Central Drugs Standard Control Organisation. CDSCO. India’s national drug regulator, including Schedule M good manufacturing practice requirements.
  2. World Health Organization. Guideline on data integrity (TRS 1033, Annex 4). WHO guidance setting out ALCOA+ principles for data integrity.
  3. US Electronic Code of Federal Regulations. 21 CFR Part 11: Electronic Records; Electronic Signatures. US FDA requirements relevant to exporters using electronic records.
  4. ICH. Quality guidelines. International guidelines including Q10 on pharmaceutical quality systems.
  5. NIST. AI Risk Management Framework. Voluntary framework for managing risks of AI systems.